Procter & Gamble (NYSE:PG) Price Target Raised to $190.00 at Citigroup

Procter & Gamble (NYSE:PG) had its price objective upped by stock analysts at Citigroup from $177.00 to $190.00 in a research report issued on Wednesday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. Citigroup’s target price points to a potential upside of 14.79% from the company’s current price.

A number of other brokerages also recently weighed in on PG. StockNews.com upgraded Procter & Gamble from a “hold” rating to a “buy” rating in a report on Tuesday, June 25th. Barclays increased their price target on Procter & Gamble from $168.00 to $170.00 and gave the stock an “overweight” rating in a report on Tuesday, April 23rd. Deutsche Bank Aktiengesellschaft reduced their target price on Procter & Gamble from $172.00 to $171.00 and set a “buy” rating for the company in a research note on Monday, April 22nd. BNP Paribas initiated coverage on Procter & Gamble in a research note on Monday, June 24th. They issued an “outperform” rating and a $187.00 target price for the company. Finally, Argus raised their target price on Procter & Gamble from $180.00 to $185.00 and gave the company a “buy” rating in a research note on Thursday, April 25th. Six research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat, Procter & Gamble has an average rating of “Moderate Buy” and a consensus target price of $171.74.

Procter & Gamble Stock Down 0.8 %

Shares of NYSE:PG opened at $165.52 on Wednesday. The firm has a market cap of $390.65 billion, a P/E ratio of 27.05, a P/E/G ratio of 3.18 and a beta of 0.41. The company has a quick ratio of 0.48, a current ratio of 0.69 and a debt-to-equity ratio of 0.49. Procter & Gamble has a 12-month low of $141.45 and a 12-month high of $169.41. The business has a fifty day simple moving average of $166.07 and a 200 day simple moving average of $159.94.

Procter & Gamble (NYSE:PG) last issued its quarterly earnings results on Friday, April 19th. The company reported $1.52 earnings per share for the quarter, topping analysts’ consensus estimates of $1.42 by $0.10. Procter & Gamble had a return on equity of 33.91% and a net margin of 18.00%. The firm had revenue of $20.20 billion during the quarter, compared to the consensus estimate of $20.43 billion. During the same period last year, the business posted $1.37 EPS. The business’s revenue was up .6% compared to the same quarter last year. Analysts predict that Procter & Gamble will post 6.55 earnings per share for the current year.

Insiders Place Their Bets

In other Procter & Gamble news, insider Moses Victor Javier Aguilar sold 9,149 shares of Procter & Gamble stock in a transaction that occurred on Thursday, May 16th. The shares were sold at an average price of $167.72, for a total transaction of $1,534,470.28. Following the transaction, the insider now owns 12,929 shares of the company’s stock, valued at approximately $2,168,451.88. The transaction was disclosed in a legal filing with the SEC, which is available through this link. In related news, CEO R. Alexandra Keith sold 855 shares of Procter & Gamble stock in a transaction that occurred on Monday, April 22nd. The shares were sold at an average price of $158.50, for a total value of $135,517.50. Following the sale, the chief executive officer now owns 4,004 shares of the company’s stock, valued at approximately $634,634. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Moses Victor Javier Aguilar sold 9,149 shares of Procter & Gamble stock in a transaction that occurred on Thursday, May 16th. The stock was sold at an average price of $167.72, for a total transaction of $1,534,470.28. Following the completion of the sale, the insider now directly owns 12,929 shares in the company, valued at approximately $2,168,451.88. The disclosure for this sale can be found here. Insiders have sold a total of 154,544 shares of company stock valued at $25,413,051 in the last 90 days. 0.17% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Procter & Gamble

A number of hedge funds have recently modified their holdings of PG. Advantage Trust Co bought a new stake in Procter & Gamble during the 4th quarter valued at $28,000. Naples Money Management LLC bought a new stake in Procter & Gamble during the 4th quarter valued at $29,000. Ruedi Wealth Management Inc. raised its holdings in Procter & Gamble by 64.7% during the 1st quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company’s stock valued at $32,000 after acquiring an additional 77 shares during the period. Transcendent Capital Group LLC bought a new stake in Procter & Gamble during the 4th quarter valued at $31,000. Finally, MeadowBrook Investment Advisors LLC bought a new stake in Procter & Gamble during the 4th quarter valued at $33,000. Institutional investors own 65.77% of the company’s stock.

About Procter & Gamble

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.